“A Lot More Asymptomatic Cancer Out There”: Major MCED Trial Hints at Complicated Future
About this episode
The episode discusses the findings of the NHS-Galleri trial and its implications for cancer detection and screening.
The prospective randomized NHS-Galleri multicancer early detection trial didn’t meet its primary endpoint, but it did uncover a lot more early-stage cancers than predicted. Eric Klein, MD, and Robert Figlin, MD, talk about what the data reveal about cancer biology and for screening programs.
People in this episode
Guests: Eric Klein, MD, Robert Figlin, MD
Topics covered
- multicancer early detection
- cancer biology
- screening programs
- clinical trials
- asymptomatic cancer
Mentioned in this episode
Organizations: NHS-Galleri, Oncology News Central
More episodes of Oncology News Central Peer-Spectives
- “The Ever-Shifting and Chaotic” State of CLL Care: What New Data Mean for Practice
- How “Drastically Better” Treatments for Some Colorectal Cancers Are Changing Care
Explore listener stats, chart rankings, contacts and more on the Oncology News Central Peer-Spectives podcast page.